FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. حسب Laura L. Stafman (6577184)

"…When tumors reached an average of 150 mm³, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …"

<i>Ep300</i> siRNA suppressed osteoblast differentiation and decreased histone lactylation levels. حسب Erika Minami (17583343)

MVK activates microglia and decreases phagocytosis. حسب Ren Y. Sato (16914027)

Tax expression is associated with decreased cellular motility. حسب Saumya Ramanayake (7879091)

Metformin pre-treatment retains an antioxidant effect and decreases apoptosis, in an AMPK activation manner. حسب Silvia Siteni (10344070)

Fig 5 - حسب Saeed El-Ashram (710370)

Variable importance plot (mean decrease accuracy and mean decrease Gini). حسب Fernando Martinez-Taboada (8655132)

Analgesic effect of morphine (4 mg/kg) was decreased after consecutive daily injections in NAMT. حسب Ghazaleh Ghamkharinejad (11414825)

Cell viability of U-87 MG cell cultures treated with Ser/5-HT or fluoxetine. حسب Glaucia Vilar-Pereira (686134)

Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. حسب Aeron M. Small (9617751)

"…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …"

The monoterpene 1,8-cineole decreased parasitemia levels in vitro. حسب Edgleyson C. dos Santos (12536575)

Flowchart of study selection. حسب Alejandro Piscoya (782326)

الموضوعات:

Description of characteristics of included studies. حسب Alejandro Piscoya (782326)

الموضوعات:

Effect of remdesivir on invasive ventilation at 14 days. حسب Alejandro Piscoya (782326)

الموضوعات:

Effect of remdesivir on all-cause mortality at 14 days. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. حسب Joseph Rabin (7399436)

الموضوعات:

Effect of atipamezole or efaroxan (0.5 mg·kg⁻¹) (Protocol 2). حسب Yoichiro Kitajima (4319455)

الموضوعات: